InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Wave Life Sciences, Inc.

WVE Clue Score51
United States Fiscal year ends December CIK 0001631574 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

53
Insider
Date
Role
Action
Shares
Price
Amount
Adrian Rawcliffe
12 Aug 2026
Director
Sold on a plan
12,700
$5.29
$67.18K
Aik Na Tan
11 Aug 2026
Director
Sold on a plan
432
$6.01
$2.60K
Ken Takanashi
11 Aug 2026
Director
Sold on a plan
3,864
$6.01
$23.22K
Heidi L Wagner
11 Aug 2026
Director
Sold after exercise
7,000
$6.01
$42.07K
Ra Capital Management, L.p.
30 Mar 2026
Director
Buy indirect
971,091
$6.50
$6.31M
Ra Capital Management, L.p.
27 Mar 2026
Director
Buy indirect
2,495,623
$6.43
$16.05M
Ra Capital Management, L.p.
26 Mar 2026
Director
Buy indirect
351,224
$6.38
$2.24M
Ra Capital Management, L.p.
26 Mar 2026
Director
Buy indirect
4,954,558
$6.06
$30.02M
Chris Francis
26 Feb 2026
See Remarks
Sold after exercise
15,294
$15.00
$229.41K
Chris Francis
26 Feb 2026
See Remarks
Sold after exercise
17,900
$15.09
$270.18K
Chandra Vargeese
9 Feb 2026
See Remarks
Sell
3,228
$13.45
$43.42K
Chris Francis
9 Feb 2026
See Remarks
Sell
1,883
$13.45
$25.33K
Paul Bolno
9 Feb 2026
President and CEO
Sell
10,480
$13.45
$140.96K
Kyle Moran
9 Feb 2026
Chief Financial Officer
Sell
3,588
$13.45
$48.26K
Chris Francis
2 Jan 2026
See Remarks
Sold after exercise
1,295
$16.70
$21.63K
Chris Francis
2 Jan 2026
See Remarks
Sold after exercise
8,080
$15.92
$128.63K
GSK plc
11 Dec 2025
10% owner
Buy indirect
1,470,000
$19.00
$27.93M
Kyle Moran
9 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$20.03
$1.00M
Kyle Moran
9 Dec 2025
Chief Financial Officer
Sold after exercise
36
$20.25
$729.00
Mark Corrigan
8 Dec 2025
Director
Sold on a plan
6,515
$14.07
$91.63K
Mark Corrigan
8 Dec 2025
Director
Sold on a plan
9,600
$13.09
$125.66K
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$18.00
$900.00K
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$13.20
$660.00K
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$15.00
$750.00K
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
60,000
$13.20
$792.00K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
22,500
$14.08
$316.80K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
50,000
$16.00
$800.00K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
122,349
$14.20
$1.74M
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
17,900
$15.00
$268.50K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
37,500
$14.08
$528.00K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
9,375
$15.00
$140.63K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
45,882
$14.50
$665.29K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
107,400
$14.56
$1.56M
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
28,125
$14.50
$407.81K
Gregory L. Verdine
8 Dec 2025
Director
Sold on a plan
7,980
$14.05
$112.12K
Gregory L. Verdine
8 Dec 2025
Director
Sold on a plan
12,020
$13.09
$157.34K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
21,000
$12.75
$267.75K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
21,000
$12.75
$267.75K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
25,000
$15.00
$375.00K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
20,000
$12.75
$255.00K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
17,230
$15.00
$258.45K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
15,000
$12.75
$191.25K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
7,494
$15.00
$112.41K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
7,494
$12.75
$95.55K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
30,000
$18.02
$540.60K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
15,000
$14.07
$211.05K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
42,000
$12.75
$535.50K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
6,445
$12.75
$82.17K
Heidi L Wagner
8 Dec 2025
Director
Sold after exercise
7,000
$14.00
$98.00K
Heidi L Wagner
8 Dec 2025
Director
Sold after exercise
7,000
$13.00
$91.00K
Adrian Rawcliffe
8 Dec 2025
Director
Sold after exercise
42,000
$15.00
$630.00K
Ra Capital Management, L.p.
13 Nov 2025
Director
Buy indirect
1,000
$6.69
$6.69K
Adrian Rawcliffe
13 Nov 2025
Director
Sold on a plan
16,115
$6.79
$109.42K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 35
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 5,330,778
History held since 18 Nov 2015